Objectives: The present study was an attempt at investigating whether the aqueous extract of Emblica officinalis may have an ameliorative effect on ochratoxin-induced lipid peroxidation in the kidney and liver of mice. Methods: Adult male albino mice were orally administered 50 μg (LD, low dose) and 100 μg (HD, high dose) of ochratoxin/0.2 ml of olive oil/animal/ day for 45 days. Results: The results revealed a significant (p < 0.05), dose-dependent increase in lipid peroxidation as well as a decreased activity of enzymatic antioxidants (superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase and glutathione transferase) and non-enzymatic antioxidants (glutathione and total ascorbic acid) in both the organs, as compared to the findings for olive oil-treated control group. Administration of Emblica officinalis aqueous extract (2 mg/animal/day) and ochratoxin for a period of 45 days caused a significant amelioration in the ochratoxin-induced lipid peroxidation in mouse liver and kidney.
INTRODUCTION
About 75-80% of the world's population depends on herbal medicine for primary health care, both in the developing and developed countries. Herbs are believed to be well compatible with the human body and to produce less side effects than the pharmaceuticals. Herbal medicine has already been mentioned in the Indian Ayurveda and Unani medicines, but the data on animal studies and efficacy of herbal preparations are not available and, therefore, these products cannot be placed either on the local, Indian, market, or on foreign markets. During the last two decades, scientists have been seeking for new plant products that possess antioxidant properties and may play a role in the prevention of various diseases associated with oxidative stress, such as cancer, and cardiovascular, reproductive and neurodegenerative diseases.
Ochratoxin is a toxic secondary fungal metabolite produced by Aspergillus ochraceus and Penicillium verdicatum [1] . Human exposure to ochratoxin is a widespread problem in some of the European countries as well as in India. The contamination of various food products by this group of mycotoxins leads to ochratoxicosis both in humans and animals [2] . Ochratoxin A is primarily a nephrotoxic agent and has been classified as a possible human carcinogen (Group 2B) by the International Agency for Research on Cancer (IARC), Lyon, France. Ochratoxin A has been shown to induce renal adenomas and carcinomas in mice and rats (IARC, 1993) . Ochratoxin exposure was found to be a putative cause of the Balkan endemic nephropathy (BEN) [3] . The chemical was found to exert hepatotoxic, cytotoxic and carcinogenic effect on various laboratory animals and on humans [4] . Emblica officinalis (Amla) , normally known as Indian gooseberry, has been used extensively in the ancient Indian Ayurveda as a potent rasayana i.e. a herbal formulation that helps attain longevity and rejuvenation [5] . It is a member of a small genus Emblica (family Euphorbiacae) which is commonly found in India and South East Asia. The fruit is a major constituent of chyavanprash [6] , a traditional Ayurvedic herbal jam also used for pickle preparation in India. Emblica officinalis is one of the myrobalans (plants that exhibit various therapeutic properties) commonly used in triphala (three fruits) preparations. Triphala is a traditional Ayurvedic herbal formulation which is considered an important rasayana in Ayurvedic medicine [7] . The rasayana medications are believed to promote health, immunity and longevity. Emblica officinalis extract has been shown to possess high antioxidative, anticancer, lipid-lowering, antisclerotic, hepatoprotective, and anti-HIV potentials [8] [9] [10] . Emblica officinalis is highly nutritious and it is an important dietary source of vitamin C, minerals and amino acids. In the edible fruit tissue, the protein concentration is three times as high as in the apple, and of ascorbic acid concentration, 160 times as high. Emblica officinalis contains a range of polyphenols, especially tannins, and other phenolic compounds. These include hydrolysable tannins (10-12%) with a molecular weight of less than 1000, including quercetin, emblicanin A, emblicanin B, punigluconin and pedunculagin [11] . They show cytoprotective activity and a possible inhibitory effect on carcinogenesis, mutagenesis and tumor genesis [12] . The present study was undertaken to evaluate the possible ameliorative effect of the aqueous extract of Emblica officinalis (amla) on ochratoxin-induced lipid peroxidation and its antioxidant defense mechanism in the kidney and liver of mice.
MATERIALS AND METHODS
All the chemicals used in the present study were of analytical grade; they were obtained from HiMedia Laboratories Pvt. Ltd, Mumbai.
Seventy animals were divided into seven groups and caged separately. Group 1 animals (untreated controls) were maintained without any treatment. Animals of Groups 2 and 3 received olive oil (0.2 ml/animal/day) and Emblica officinalis aqueous extract (2 mg/animal/day), respectively, for 45 days, and served as pre-treatment controls. Animals of groups 4 and 5 were orally administered ochratoxin at 50 μg (LD, low dose) and 100 μg (HD,high dose) in 0.2 ml olive oil/animal/day (1.5 and 3.0 mg/kg b.w./day) for 45 days. Group 6 and 7 animals were orally given ochratoxin, as described for groups 4 and 5, and aqueous extract of Emblica officinalis (2 mg/animal/day) for 45 days, Table 1 . Olive oil was obtained from Figaro, Madrid, Spain. Ochratoxin was dissolved in olive oil and was used as a vehicle in Group 2. Ochratoxin dose was based on WHO Environmental Health Criteria for ochratoxin and trichothecenes [20] . The dose of Emblica officinalis aqueous extract was based on earlier studies [21] . All the agents were administered orally for 45 days, using a feeding tube attached to a hypodermic syringe.
Biochemical analysis
On completion of the treatment, the animals were sacrificed by cervical dislocation. In all the control and treated groups of animals, the kidneys and livers were quickly isolated, blotted free of blood and utilized for biochemical analyses, The 10% homogenate for lipid peroxidation (LPO) was prepared by homogenizing a known amount of tissue in phosphate-buffered saline (PBS). The LPO was assessed using the method of Ohkawa et al. (1979) which consists in quantifying the thiobarbituric acid reactive substances (TBARS) [22] . The homogenate for superoxide dismutase (SOD) was prepared by homogenizing a known amount of tissue in cold normal saline. SOD activity was measured by modified spectrophotometric method of Kakkar et al. (1984) [23] . For the preparation of glutathione peroxidase (GPX) and catalase (CAT) homogenate, a known amount of tissue was homogenized in 0.1% chilled digitonin. GPX and CAT activities were assayed using modified methods of Pagila and Valentine (1967) , and Luck (1963) , with mortar and pestle. 5 gm of powder was suspended in 100 ml distilled water and mixed repeatedly for 3 hours at 40°C. After cooling, the content was filtered successively through ordinary and Whatman filter paper No. 1. Both the fractions were dried and stored in dark bottles at 4°C. During the experiment, a known amount of dried extract was redissolved in water and used. The tannin content in the crude extract of Emblica officinalis was determined by oxidation-reduction titration using indigo-caramine reagent [17] . A known amount of dry extract was boiled in distilled water and filtered. The filtrate was treated with indigo-caramine reagent. The solution was then titrated with 0.1 N potassium permanganate solution. The endpoint was the appearance of a yellowish green colour. The flavonoid content was determined by the method of Chang et al. [18] . Plant extract in methanol was mixed separately with aluminum chloride and potassium acetate along with distilled water. The absorbance of the reaction mixture was measured at 415 nm. Total ascorbic acid was estimated by the method of Chinoy et al. [19] . The blue dye, dichlorophenol indophenol, is reduced to a colourless form on addition of ascorbic acid, where ascorbic acid reduces to dehydroascorbic acid. The buffered HPO 3 extract was treated with dichlorophenol indophenol dye solution. The absorbance was read at 520 nm. Emblica officinalis aqueous extract was found to contain 3.4% ascorbic acid, 2.2% tannin and 0.7% flavonoid of dry weight.
Animal experiment
Young adult male inbred Swiss albino mice (Mus musculus), weighing approximately 30-33 g, were obtained from Zydus Research Centre, Ahmedabad, India. The animals were provided with animal feed and water ad libitum and kept in 12 h:12 h light/dark cycles at 26±2°C. Animal feed was prepared as per the formulation obtained from the National Institute of Occupational Health, Ahmedabad, India, and was confirmed to be free of mycotoxins. Guidelines for Animal Care and Use in Scientific Research, 1991, published by the Indian National Science Academy, New Delhi, India, were followed. and antioxidant defense mechanism in mouse kidney. No significant changes were observed between the different control groups (Groups 1, 2, 3). In mice receiving ochratoxin (Groups 4, 5), a significant dose-dependent increase in lipid peroxidation, detected by measuring renal TBARS concentration, was found (LD: 3.55±0.37; HD: 4.54±0.85), as compared to the findings for the vehicle controls (Group 2). [24, 25] . The homogenate for glutathione reductase (GRX) determination was prepared by homogenizing a known amount of tissue in 5 ml of 1% bovine serum albumin, and for glutathione transferase (GST) analysis, a 10% tissue homogenate was prepared in phosphate buffer. GRX and GST activities were assessed according to Mavis and Stellwagen (1968) , and Habig et al. (1967) , respectively [26, 27] . All the samples were analyzed for protein content by the method of Lowry et al. (1951) [28] . For reduced glutathione (GSH) analysis, a known amount of tissue was homogenized in 3 ml of 3% metaphosphoric acid and 1 ml distilled water saturate with salt solution. For the total ascorbic acid (TAA), the homogenate was prepared in 10 ml Norit reagent. GSH and TAA concentrations were determined according to Grunert and Philips (1951) and Roe and Kuether (1943) , respectively [29, 30] .
Statistical analysis
The results are expressed as means ±SD. The data were analyzed statistically using one-way analysis of variance (ANOVA) followed by the Tukey test. The level of significance was adopted at p ≤ 0.05. The P values were compared between different study groups Table 1 presents the study protocol for the experiment. Table 2 shows the effect of ochratoxin and ochratoxin with Emblica officinalis aqueous extract on lipid peroxidation Abbreviations as in Table 2 IJOMEH 2010;23(1)
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DISCUSSION
The results shown in the tables clearly indicate a significant increase in lipid peroxidation (LPO) and a decrease in the activity of enzymatic and non-enzymatic antioxidants in the kidney (Table 2 ) and liver ( [32] . Increased malondialdehyde (MDA) production, indicating LPO increase, was reported earlier in vitro [33] . Petrik et al. (2003) demonstrated that a very low concentration of ochratoxin was sufficient to induce apoptosis and oxidative damage to kidney cells in Wistar rats [34] . The intracellular glutathione status appears to be a sensitive indicator of the cell's overall condition and its ability to counteract a toxic challenge [35] . Decreased glutathione concentration may be due to a continuous attack of free radicals. The ability of ochratoxin to react with reduced glutathione (GSH) was reported by Dai et al. [36] . Ascorbic acid is transformed to L-dehydroascorbate during free radical scavenging. Our results indicating a significant reduction in glutathione and ascorbic acid concentrations corroborate with the findings of Atroshi et al. [37] .
The decrease in the activity of non-enzymatic antioxidants in the cell increases the susceptibility to injury due to peroxidation.
The levels of enzymatic antioxidants (superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase and glutathione transferase) were significantly lower in ochratoxin-treated mice than in the vehicle controls (Group 2). Superoxide radicals (O 2 -) have been reported in several pathological disorders. A decrease in caused a significant amelioration of the ochratoxin-induced lipid peroxidation in the kidney of mice receiving ochratoxin and Emblica officinalis (Groups 6, 7) than in the animals treated with ochratoxin alone (Groups 4, 5). Table 3 shows the effect of ochratoxin and ochratoxin with Emblica officinalis on lipid peroxidation and antioxidant defense mechanism in mouse liver. The results revealed no significant alterations in lipid peroxidation between the different control groups (Groups 1, 2, 3 ). The level of lipid peroxidation was significantly higher in ochratoxin-treated mice than in the vehicle controls (Groups 4, 5). The effect was dose-dependent (LD: 4.45±0.18; HD: 6.22±0.15). Table 3 also shows the effect of ochratoxin and ochratoxin with Emblica officinalis on total ascorbic acid and glutathione concentrations as well as on the activity of catalase, superoxide dismutase, glutathione peroxidase, glutathione reductase and glutathione transferase in mouse liver. The results revealed no significant alterations between the different control groups (Groups 1, 2, 3). Total ascorbic acid and glutathione concentrations were significantly lower in ochratoxin-treated mice than in the vehicle controls (Group 2). The effect was dose-dependent (total ascorbic acid -LD: 3.53±0. antioxidant defense activity and acts as a powerful inhibitor of lipid peroxidation [43] . Oral administration of Emblica officinalis aqueous extract and ochratoxin also produced a significant increase in glutathione and ascorbic acid concentrations in mouse liver and kidney. This observation implies that the extract used in the present experiment has a potential to diminish ochratoxin-induced toxicity in all these major body organs. Increased concentration of glutathione and ascorbic acid decreases the cell's vulnerability to oxidant attack. Sharma et al. reported that the Emblica officinalis extract was found to increase the level of reduced glutathione thus showing an antimutagenic activity in mice exposed in vivo to cyclophosphamide [44] . Anilakumar et al. noted that the aqueous extract of Emblica officinalis increased the level of hepatic ascorbic acid and glutathione in rats [45] .
Oral administration of the aqueous extract of Emblica officinalis and ochratoxin caused a significant increase in the activity of superoxide-dismutase, catalase, glutathione peroxidase, glutathione reductase and glutathione transferase (Groups 6, 7) compared to the findings for mice treated with ochratoxin alone (Groups 4, 5, 7). The extract of the Emblica officinalis fruit, where pyrogallol was an active component, was found to inhibit proliferation of four human tumour cell lines in vitro [46] . Increased activity of catalase, superoxide dismutase, glutathione peroxidase, glutathione reductase and glutathione transferase was reported in gamma-radiated mice treated with Emblica officinalis [47] . The aqueous extract of Emblica officinalis was found to modulate the increase in the activity of antioxidant enzymes in cyclophosphamide-treated animals [48] . Emblicanin A (37%) and Emblicanin B (33%) enriched fraction of fresh juice of the Emblica fruit was found to exert antioxidant effect on ischaemic reperfusion-induced (IRI) oxidative stress in rat heart [49] . [38] [39] . In the case of ochratoxicosis, a decrease in the activity of these enzymes could be due to a number of factors. First of all, the toxin decreases the rate of protein biosynthesis by competitively inhibiting phenylalanine tRNA synthetase, and it decreases the production of these enzymes. Secondly, the toxin produces reactive oxygen species (ROS) that directly or indirectly interact with proteins (enzymes), DNA and RNA, and alter their activity, thus affecting the overall production of enzymes. A decrease in the DNA, RNA and protein ratios would affect the transcription and translation processes, ultimately having impact on the synthesis of various enzymes [40] . The oxidative stress and its involvement in the mechanism of ochratoxin-induced toxicity and oxidation of proteins have been reported earlier [41] . Oral administration of Emblica officinalis aqueous extract at the time of ochratoxin exposure significantly decreased the extent of lipid peroxidation. This may have been due to the presence of radical scavengers showing antioxidant property that have a capacity to decrease the formation of peroxides, hydroxyl and superoxide radicals. Our findings are consistent with those of Khopde et al. [42] . Vitamin C present in the fresh fruit extract maintains the first natural antioxidant. Emblicanin B in turn attacks free radicals and is transformed into emblicanin oligomers. This makes Emblicanin one of the best free radical scavenging antioxidants. Oral administration of Emblica officinalis to mice treated with dimethylbenzyl anthracene caused a significant increase in the activity of hepatic antioxidants, mainly glutathione, glutathione peroxidase, glutathione transferase and glutathione reductase [50] . Vitamin C has been found to be an important antioxidant present in the extract. Emblica officinalis fruit normally contains ascorbic acid (0.4 % w/w), and vitamin C accounts approximately for 45-70% of the antioxidant activity [51] .
